August 2026: Healthcare M&A Snapshot

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in August 2026 below.
Notable Sector Deals: August 2026
Hg’s majority investment in Nourish Care
A significant digital health transaction, with Hg acquiring a majority stake in Nourish from Livingbridge, which will remain invested as a minority shareholder
Founded in 2011, Nourish provides digital care management software that helps residential and home care providers plan, record and coordinate care
Livingbridge has supported Nourish since 2022, including its acquisition of CarePlanner in 2023, which expanded the business into the home care market
Hg’s investment will support further product development and the use of AI to reduce administrative demands on carers, reflecting continued investor appetite for mission-critical software across the care sector
Radiology Partners’ acquisition of Everlight Radiology
Another international teleradiology deal, with US-based Radiology Partners agreeing to acquire Everlight Radiology from Livingbridge
Everlight operates a global network of more than 800 radiologists across more than 40 countries, reporting more than 2.5 million scans annually
The acquisition will combine Everlight with Radiology Partners’ vRad business, creating a global teleradiology platform providing continuous subspecialist coverage across the US, UK, Ireland, Australia, New Zealand and South Africa
The deal continues a period of activity across UK teleradiology, following transactions involving Medica, 4ways and Axon Diagnostics
Ethos Partners’ investment in Labyrinth
An interesting dental lab sector investment for Ethos Partners, backing Labyrinth Dental Laboratory Group’s founding management team to accelerate the company’s next phase of growth
Headquartered in Birmingham, Labyrinth is the UK’s fourth-largest full-service dental laboratory group, serving more than 2,000 NHS and private dentists through eight specialist laboratories located on a single site
Ethos’ investment will support the roll-out of free intraoral scanners and training to customers, deepening relationships with dentists and accelerating the transition from traditional impressions to digital workflows
Agentis’ acquisition of Clinical Pharmacist Solutions
A highly complementary second acquisition for LDC-backed Agentis Health Group, strengthening its clinical capabilities through the addition of outsourced pharmacy specialist Clinical Pharmacist Solutions
Founded in 2019, CPS provides clinical pharmacists, medicines optimisation services and training to primary care organisations
Agentis was established from Ashtons Hospital Pharmacy Services and launched in 2025 with the acquisition of Living With
Combining CPS’s clinical workforce with Agentis’ digital capabilities creates a more integrated model for managing long-term conditions, aligned with the NHS’s movement towards community-based and preventative care
Healthcare Market Activity: August 2026
Private Equity Activity
Sub-sector | Target | Acquirer / Investor | Exiting PE |
Clinical Services | Everlight Radiology | Radiology Partners | Livingbridge |
Children’s Services | Forge Care | Endurance Capital | FPC (partial exit) |
Clinical Services | Clinical Pharmacist Solutions | Agentis (LDC) | N/A |
Occupational Health | Medmark | Phoenix Equity Partners | N/A |
Digital Health | Nourish Care | Hg | Livingbridge (partial exit) |
Specialist Care | Elysium Cymru | Iris Care (Ancala) | N/A |
Medical Equipment | Montcalm International | Winncare (Siparex) | N/A |
Dental Labs | Labyrinth Dental Laboratory Group | Ethos Partners | N/A |
Pharma Services | tranScrip* | TMC Pharma (LDC) | N/A |
Venture Capital Activity
Target | Description | Lead Investor | Investment |
Mironid | Therapeutics for kidney disease | Scottish National Investment Bank | $46m |
Online diagnostic imaging booking platform | Noteus Partners | $220m** |
*Acquired out of administration
**Includes equity and debt




Comments